This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Neal S. Young, MD

JAMA. 1994;271(12):935-938.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASES

Patient 1

A 60-year-old man with moderately severe congestive heart failure secondary to cardiomyopathy was treated with an experimental inotropic drug, vesnarinone (Otsuka America, Rockville, Md), known to be associated with agranulocytosis. Blood cell counts were monitored weekly. Ten weeks after beginning treatment, the total white blood cell count, previously normal, was 2.6x10⁹/L with an absolute neutrophil count of 1.282x10⁹/L The patient was not symptomatic. The experimental drug was discontinued. Two days later the absolute neutrophil count was 0.396x10⁹/L. The patient was hospitalized for observation. A bone marrow aspirate showed absence of mature granulocytes and myeloid precursor cells. The patient was treated with oral cephalexin. Fever occurred to a temperature of 38.6°C (101.4°F), leading to withdrawal of an intravenous catheter. Over a week both total white blood cell and neutrophil numbers returned to normal.

Patient 2

A 75-year-old woman with severe congestive . . . [Full Text PDF of this Article]

Author Affiliations
From the Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

Footnotes
Reprint requests to Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg 10, Room 7C 103, Bethesda, MD 20892 (Dr Young).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?